Epidemiology and clinical course of PFAPA syndrome in the pediatric population-single center study

Natalia Gołuchowska1, Agata Tomaszewska2,3, Aldona Ząber2

  • 1Department of Pediatrics, Nephrology and Allergology, Military Institute of Medicine - National Research Institute, Szaserów 128, 04-141, Warsaw, Poland. goluchowskan@gmail.com.

BMC Pediatrics
|June 14, 2026
PubMed

Insights

Periodic Fever with Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) syndrome is common in children. This study characterizes PFAPA in Polish children, confirming effective treatments like prednisone and tonsillectomy.

Area of Science:

  • Pediatrics
  • Immunology
  • Genetics

Background:

  • PFAPA syndrome is the most common autoinflammatory disease in children, with an unknown cause.
  • It presents as recurrent fever episodes with specific clinical signs.

Purpose of the Study:

  • To characterize PFAPA syndrome in a large Polish pediatric cohort.
  • To analyze clinical manifestations, treatment approaches, and laboratory findings.

Main Methods:

  • Retrospective study of 47 children diagnosed with PFAPA syndrome.
  • Data collected via structured questionnaires, including clinical, therapeutic, and laboratory data.

Main Results:

  • Median age of 5 years, predominantly males (59.6%).
  • Typical symptoms include fever (mean 5 days), cervical lymphadenopathy (91.5%), tonsillar exudates (85.1%), pharyngitis (74.5%), and oral aphthae (51.1%).
  • Prednisone effective in 97.6%; tonsillectomy resolved symptoms in 83.3% of cases.

Conclusions:

  • Confirms the clinical and epidemiological profile of PFAPA in children.
  • Highlights the high efficacy of glucocorticoid therapy and tonsillectomy.
  • Aims to reduce antibiotic overuse by better understanding PFAPA.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...